55.07 USD
▲+2.72+1.06%
盘后 54.50 +0.02%
2026-08-03
市值
$9.15B
市盈率
—
EPS
-3.46
股息率
—
52 周区间
40.03 – 86.74
成交量
2.69M
Beta
0.40
目标价
89.33
52W 低 40.0352W 高 86.74
价格走势
公司简介
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric and adult patients with spinal muscular atrophy (SMA). It also ...